Friday, May 1, 2026

Caught in the Act: North Korean Ship Changes Flag to Evade Detection Near NLL

A North Korean cargo ship violated the Northern Limit Line, prompting South Korea to issue warning shots and investigate potential sanctions violations.

OUT OF CONTROL: Intelligence Watchdog Suddenly Dies—North Korea Is Officially Operating With ZERO Oversight!

The Pyongyang Papers site tracking North Korea's sanctions evasion has been suspended, impacting investigations by various agencies.

BTS FESTA 2024: Jin Delivers Love and Tunes to Thousands of Fans

The vibrant festival hosted by BTS and...

Tag: Biotech

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

Daewoong Pharmaceutical and Primind’s Strategic Investment in American Biotech General Proximity

Daewoong Pharmaceutical invests in biotech firms to enhance drug development using Induced Proximity technology and expand globally.

Cha Biotech Announces Support of K-Bio Startups at Bio Korea 2026

Cha Biotech aims to create a global innovation ecosystem for K-Bio startups through the K-Bio CIC Open Innovation Center.

Korea’s Biotech Healthcare Firms Possess Cutting-edge AI Diagnostics and Precision Medicine

South Korea's biotech sector excels in technology but needs better storytelling and governance to attract global investments.

How the 2026 Drug Price Reform Will Reshape the Pharmaceutical Industry

Experts discuss the impact of drug pricing reform on the pharmaceutical sector, urging innovation and strategic shifts in R&D investments.

Mastering U.S. Patent Risks: Essential Training for Korean Life Sciences Firms

The Korea Pharmaceutical and Bio-Pharma Association will host training on U.S. patent risks for local pharma and biotech professionals.

Revolutionary Male Contraceptive: New Method Halts Sperm Production Without Hormonal Side Effects

A Cornell team developed a reversible male contraceptive, blocking sperm production without hormonal side effects, using a compound called JQ1.

Is VRN110755 the Future of Non-Small Cell Lung Cancer Treatment? Find Out!

Voronoi's VRN110755 for NSCLC receives approval for clinical trial modifications, expanding to a Phase 1b/2 trial across multiple regions.

Celltrion’s Groundbreaking Achievement: First Asian Bio Company to Secure APEC CBPR and Global CBPR Certifications

Celltrion becomes the first South Korean biotech firm to earn APEC CBPR and Global CBPR certifications, enhancing global data protection.

Samsung Biologics Partners with Eli Lilly: How This Open Innovation Hub Will Transform K-Bio by 2027

Samsung Biologics partners with Eli Lilly to create a biotech innovation hub in Korea, enhancing growth opportunities for local firms.

Lotte Biologics at DCAT Week 2026: Unveiling Strategic Collaborations in Global CDMO

Lotte Biologics will attend DCAT Week in New York to pursue global CDMO partnerships and showcase its production capabilities.

South Korea’s Pharmaceutical Future: 500 Million USD Investment from Eli Lilly to Boost K-Bio Innovation

South Korea partners with Eli Lilly to boost biotech and pharma industries, investing $500M to enhance innovation and healthcare access.

Samsung Biologics Joins CEPI: How This Partnership Will Revolutionize Vaccine Production in Asia

Samsung Biologics partners with CEPI to enhance vaccine manufacturing, aiming to strengthen global health security and support local biotech growth.

How SK Bioscience Plans to Dominate the Global Vaccine Market in 2026

SK Bioscience enhances its operational system with new COO and key appointments to boost global competitiveness and vaccine development.

2025’s Drug Price Revolution: What Asian Pharma Firms Need to Know About MFN Policies

Trump's second term sees U.S. drug pricing reforms and supply chain shifts, prompting South Korean firms to seize new opportunities.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.